Click HERE to view Webcast

Target Audience
This educational activity is intended for medical oncologists, surgical oncologists, primary care physicians, nurses, other practicing clinicians, and healthcare administrators who are interested and/or involved in the management of breast cancer.

Overview
This online activity is a Webcast of the “13th Annual Perspectives in Breast Cancer” meeting that was held in Boston on October 5-6, 2007. The presentations encompass a multitude of topics in breast cancer, such as diagnostic and prognostic issues, surgery and radiotherapy, treatment of early and late stage disease, as well as toxicity and side effect management issues. A preconference program, titled “Challenges in Breast Cancer Nursing,” is included and is also a remarkable group of lectures.

Educational Objectives
After completing this activity, the participant will be able to:

• Identify patients who would benefit from chemoprevention and differentiate the risks and benefits of various agents
• Select the most appropriate techniques for screening, diagnosis, and initial evaluation of breast cancer
• Identify the latest and most important prognostic and predictive factors in breast cancer
• Identify and explain the appropriate therapeutic options for patients with ductal carcinoma in situ, early stage, or metastatic cancer
• Describe the latest developments in surgery, radiation therapy, and systemic therapy for the treatment of breast cancer
• Discuss effective management of side effects and toxicities secondary to oncologic therapies
• Evaluate and integrate recent clinical trial data regarding hormonal and targeted therapies into a cohesive therapeutic plan for patients
• List the most promising future strategies for the management of breast cancer
• Explain nursing issues related to breast cancer diagnosis, prognosis, and treatment, as well as feasible resolutions
  

Disclosure Statement
As a provider accredited by the Accreditation Council for Continuing Medical Education (ACCME), Imedex^®, LLC must ensure balance, objectivity, independence, and scientific rigor in its educational activities. Faculty are encouraged to provide a balanced view of therapeutic options by utilizing generic names of several to ensure impartiality.

All faculty participating in an Imedex activity are required to disclose commitments to and/or relationships with pharmaceutical companies, biomedical device manufacturers or distributors, or others whose products or services may be considered to be related to the subject matter of the educational activity. Disclosure of these commitments and/or relationships is included in these course materials so that participants in the activity may formulate their own judgments in interpreting its content and evaluating its recommendations.

The following indicates the faculty disclosure declaration information and the nature of those commercial relationships.

All materials are included with the permission of the authors.

1=grant/research support 2=consultant 3=speaker’s bureau 4=stock shareholder 5=other support

The following speakers have reported an affiliation with the supporters of this conference:

The following speakers do not report any affiliation:

Harold J. Burstein, MD, PhD
Deborah Feigel, PA
Richard J. Gray, MD
Lisa Newman, MD
Frances Palmieri, RN, MSN, OCN
Abram Recht, MD
Lupe G. Salazar, MD
Heidi Schulz, RN, OCN
Joseph A. Sparano, MD
Alphonse Taghian, MD, PhD
Brittany Thomas, MS, CGC
Frank Vicini, MD

All Imedex staff members who are in a position to control the content of this activity have no financial relationships with any commercial interests that are relevant to this activity.

Faculty
Harold J. Burstein, MD, PhD
Dana Farber Cancer Institute
Boston, Massachusetts

Maura N. Dickler, MD
Memorial Sloan-Kettering Cancer Center
New York, New York

Deborah Feigel, PA
Mayo Clinic
Jacksonville, Florida

Kevin Fox, MD
University of Pennsylvania
Philadelphia, Pennsylvania

Richard J. Gray, MD
Mayo Clinic
Scottsdale, Arizona

Charles L. Loprinzi, MD
Mayo Clinic
Rochester, Minnesota

Lisa Newman, MD
University of Michigan
Ann Arbor, Michigan

Ruth O'Regan, MD
Winship Cancer Institute
Emory University
Atlanta, Georgia

Frances Palmieri, RN, MSN, OCN
Mayo Clinic
Jacksonville, Florida

Edith A. Perez, MD
Mayo Clinic
Jacksonville, Florida

Abram Recht, MD
Beth Israel Deaconess Medical Center
Harvard Medical School
Boston, Massachusetts

Lupe G. Salazar, MD
University of Washington
Seattle, Washington

Heidi Schulz, RN, OCN
Beth Israel Deaconess Medical Center
Harvard Medical School
Boston, Massachusetts

Joseph A. Sparano, MD
Albert Einstein College of Medicine
Bronx, New York

Vered Stearns, MD
Sidney Kimmel Comprehensive Cancer
Center at Johns Hopkins
Baltimore, Maryland

Alisha Stein, RNC, BSN, OCN
Cancer Research Network
Boca Raton, Florida

Alphonse Taghian, MD, PhD
Massachusetts General Hospital Cancer Center
Boston, Massachusetts

Brittany Thomas, MS, CGC
Mayo Clinic
Rochester, Minnesota

Frank A. Vicini, MD
William Beaumont Hospital
Royal Oak, Michigan

Victor G. Vogel, MD, MHS, FACP
University of Pittsburgh School of Medicine
Pittsburgh, Pennsylvania

Sponsorship Statement
This activity is sponsored by Imedex, LLC.

Accreditation Statement
Continuing Medical Education
Imedex, LLC is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Imedex, LLC designates this educational activity for a maximum of 12 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Continuing Education for Nurses
This program has been approved by The American Association of Critical-Care Nurses (AACN) for 12 contact hours, CERP A file number 1207- A012.41/4949. Participants should claim only those hours of credit that he/she actually spent in the activity.

In order to receive credit, participants must successfully complete the post-test and complete the online evaluation form. You will receive an online CME statement of credit to print for your records.

For questions regarding the accreditation of this activity, please contact

Imedex
4325 Alexander Drive
Alpharetta, GA 30022
Fax: +1(770) 751-7334
Email: enduring@imedex.com

Unapproved and Investigational Uses of Drug and Devices
This Webcast may contain information about experimental and other uses of drugs or devices that are not currently approved by the US Food and Drug Administration (FDA) and/or other national regulatory agencies in the United States and other countries. Participants in the United States are encouraged to consult the FDA-approved product labeling for any drug or device mentioned in this program before use. Participants from other countries should consult with their respective regulatory authorities.

The opinions expressed in this email case discussion are the opinions of the authors and do not necessarily reflect the opinions of Imedex, LLC.

Support
The following companies have provided unrestricted educational grants in support of this activity: Amgen Inc; AstraZeneca Pharmaceuticals LP/Abraxis Oncology; Genentech BioOncology; Genomic Health Inc.; Novartis Pharmaceuticals Corporation; Pfizer Inc; and sanofi-aventis, U.S.

Click HERE to view Webcast

System Requirements:

is required for proper viewing. Click here to download Pentium 500 processor or greater Windows 98/NT/2000/XP or Mac OS 9/X Microsoft Internet Explorer 5.5 or later (Firefox browser currently not supported) 128 MB of RAM Monitor settings: High color at 800 x 600 pixels Sound card and speakers Audio troubleshooting For general troubleshooting concerning audio or video playback issues consult the following Web link: http://support.microsoft.com/kb/306317.